Cullinan Oncology, Inc. (CGEM) Tops Q1 EPS by 8c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($0.74), $0.08 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Bessent: U.S. will enforce 'zero leakage' approach to Iran sanctions
• Tyson Foods sets pricing on debt tender offers, hits $1.2B cap
• Carney on Trump's latest tariff threat: not a surprise U.S. would take some form of reprisal